Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL28001851 | 0.95 | TRPV4 (0.32) | TRPV4 | |
| Cyanate SCHEMBL27838660 | 0.93 | CA1 (0.31) | TRPV4CA1CA2CA4 | |
| SCHEMBL12599751 | 0.86 | — | — | |
| SCHEMBL24108197 | 0.85 | TRPV4 (0.33) | TRPV4 | |
| SCHEMBL27100882 | 0.85 | — | — | |
| SCHEMBL25788395 | 0.81 | TRPV4 (0.46) | TRPV4CYP11B1CYP11B2 | |
| SCHEMBL24147286 | 0.79 | — | — | |
| SCHEMBL1020839 | 0.78 | — | — | |
| SCHEMBL29517820 | 0.78 | EGFR (0.32) | CYP11B1CYP11B2 | |
| SCHEMBL7104591 | 0.78 | EGFR (0.32) | CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230240137-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
| US-20230240137-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20230225141-A1 | Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20230225141-A1 | Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| WO-2023117748-A1 | DISPLAY DEVICE COMPRISING A COMMON CHARGE GENERATION LAYER AND METHOD FOR MAKING THE SAME | NOVALED GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023117749-A1 | CHARGE GENERATION LAYER COMPRISING A COMPOUND OF FORMULA (I), ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING THE CHARGE GENERATION LAYER AS WELL AS COMPOUNDS OF FORMULA (I) | NOVALED GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| EP-4199096-A1 | DISPLAY DEVICE COMPRISING A COMMON CHARGE GENERATION LAYER AND METHOD FOR MAKING THE SAME | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| WO-2021259785-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021250279-A1 | ORGANIC LIGHT EMITTING DIODE AND DEVICE COMPRISING THE SAME | NOVALED GMBH (DE) | 2021-12-16 | — | — | WO | disclosed |
| US-11136296-B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2021-10-05 | — | — | US | disclosed |
| US-11136296-B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2021-10-05 | — | — | US | disclosed |
| WO-2020217129-A1 | LIGHT EMITTING DEVICE, LIGHT EMITTING APPARATUS, ELECTRONIC DEVICE AND LIGHTING DEVICE | 株式会社半導体エネルギー研究所 | 2020-10-29 | — | — | WO | disclosed |
| EP-3609869-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | Bayer Aktiengesellschaft (DE) | 2020-02-19 | — | — | EP | disclosed |
| US-20200031775-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031775-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-01-30 | — | — | US | disclosed |
| CN-110730776-A | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and their use | 拜耳股份公司 | 2020-01-24 | — | — | CN | disclosed |
| WO-2018189011-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2018-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200031775-A1 | SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF | AADAC, NAT1, EPX | TRPV4 2318/4885CYP11B1 906/4885CYP11B2 295/4885 |
| US-11136296-B2 | Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof | AADAC, NAT1, EPX | TRPV4 2318/4885CYP11B1 906/4885CYP11B2 295/4885 |
| US-20230240137-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP2C19, CYP2C9 | TRPV4 1053/4885CYP11B1 169/4885CYP11B2 125/4885 |
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP2C19, CYP2C9 | TRPV4 851/4885CYP11B1 115/4885CYP11B2 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.